Antibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 11527-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- UCHL5 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated UCHL5 antibody (Cat. #11527-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IHC, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Anti-tumor effects of deubiquitinating enzyme inhibitor PR-619 in human chondrosarcoma through reduced cell proliferation and endoplasmic reticulum stress-related apoptosis.
Caveolin-2 in association with nuclear lamina controls adipocyte hypertrophy.
The UCHL5 inhibitor b-AP15 overcomes cisplatin resistance via suppression of cancer stemness in urothelial carcinoma.
Ubiquitin C-Terminal Hydrolase L5 (UCHL5) Accelerates the Growth of Endometrial Cancer via Activating the Wnt/β-Catenin Signaling Pathway.
Proteasome-associated cysteine deubiquitinases are molecular targets of environmental optical brightener compounds.
Computational and biochemical studies of isothiocyanates as inhibitors of proteasomal cysteine deubiquitinases in human cancer cells.
Lin WC, Chiu YL, Kuo KL, Chow PM, Hsu CH, Liao SM, Dong JR, Chang SC, Liu SH, Liu TJ, Hsu FS, Wang KC, Lin YC, Chang CC, Huang KY
American journal of cancer research 2023;13(7):3055-3066
American journal of cancer research 2023;13(7):3055-3066
Caveolin-2 in association with nuclear lamina controls adipocyte hypertrophy.
Choi M, Kwon H, Pak Y
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2023 Feb;37(2):e22745
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2023 Feb;37(2):e22745
The UCHL5 inhibitor b-AP15 overcomes cisplatin resistance via suppression of cancer stemness in urothelial carcinoma.
Chow PM, Dong JR, Chang YW, Kuo KL, Lin WC, Liu SH, Huang KH
Molecular therapy oncolytics 2022 Sep 15;26:387-398
Molecular therapy oncolytics 2022 Sep 15;26:387-398
Ubiquitin C-Terminal Hydrolase L5 (UCHL5) Accelerates the Growth of Endometrial Cancer via Activating the Wnt/β-Catenin Signaling Pathway.
Liu D, Song Z, Wang X, Ouyang L
Frontiers in oncology 2020;10:865
Frontiers in oncology 2020;10:865
Proteasome-associated cysteine deubiquitinases are molecular targets of environmental optical brightener compounds.
Castro I, Ekinci E, Huang X, Cheaito HA, Ahn YH, Olivero-Verbel J, Dou QP
Journal of cellular biochemistry 2019 Aug;120(8):14065-14075
Journal of cellular biochemistry 2019 Aug;120(8):14065-14075
Computational and biochemical studies of isothiocyanates as inhibitors of proteasomal cysteine deubiquitinases in human cancer cells.
Ahmed ZSO, Li X, Li F, Cheaito HA, Patel K, Mosallam EM, Elbargeesy GAEH, Dou QP
Journal of cellular biochemistry 2018 Nov;119(11):9006-9016
Journal of cellular biochemistry 2018 Nov;119(11):9006-9016
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- mouse colon tissue were subjected to SDS PAGE followed by western blot with 11527-1-AP( UCHL5 Antibody) at dilution of 1:300
- Sample type
- tissue
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The UCHL5 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human UCHL5. This antibody recognizes human,mouse,rat antigen. The UCHL5 antibody has been validated for the following applications: ELISA, IHC, WB analysis.